Emerging ways to treat breast cancer: will promises be met?
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 605, doi. 10.1007/s13402-018-0409-1
- By:
- Publication type:
- Article
Works matching IS 22113428 AND DT 2018 AND VI 41 AND IP 6
Results: 9
1
2
The emerging role of lncRNAs in the regulation of cancer stem cells.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 585, doi. 10.1007/s13402-018-0406-4
- By:
- Publication type:
- Article
3
Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 663, doi. 10.1007/s13402-018-0404-6
- By:
- Publication type:
- Article
4
Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 693, doi. 10.1007/s13402-018-0402-8
- By:
- Publication type:
- Article
5
CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 687, doi. 10.1007/s13402-018-0401-9
- By:
- Publication type:
- Article
6
In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 677, doi. 10.1007/s13402-018-0400-x
- By:
- Publication type:
- Article
7
Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 651, doi. 10.1007/s13402-018-0399-z
- By:
- Publication type:
- Article
8
Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 637, doi. 10.1007/s13402-018-0398-0
- By:
- Publication type:
- Article
9
Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 6, p. 623, doi. 10.1007/s13402-018-0397-1
- By:
- Publication type:
- Article